Skip to main content
Fig. 2 | BMC Biotechnology

Fig. 2

From: Use of immunoinformatics and the simulation approach to identify Helicobacter pylori epitopes to design a multi-epitope subunit vaccine for B- and T-cells

Fig. 2

Analysis of the PROSA-web server and the Ramachandran plot; A and B shows 27 bad angels (A897 ILE-A898 ASN), A876 PHE, A911 TRP, (A725 PRO-A726 PRO), A566 ASP, A544 ASP, (A724 ILE-A725 PRO), (A900 GLY-A901 LEU), A896 SER, A549 PHE, A751 ASP, A898 ASN, (A583 ASN-A584 PRO), A833 ASP, A782 SER, A686 HIS, A556 HIS, A514 ASP, (A1003 GLU-A1004 PRO), A563 HIS, A512 TRP, (A536 ILE-A537 ASP), A595 ASP, (A1006 ARG-A1007 GLY), A524 HIS, A673 HIS); C shows amino acid distribution in desired (82.5% of residues), permissible (15% of residues), and impermissible (2.4% of residues) areas using the Ramachandran plot. D, E Validation tools like Verify 3D, and ERRAT was showed the quality of the tertiary structure of vaccine was **95.108

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us